| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $176,647 | 11 | 100 |
Sells | $0 | 0 | 0 |
| Bond Ryan | director | 1 | $50,059 | 0 | $0 | $50,059 |
| Ness Brent | Chief Executive Officer | 3 | $32,152 | 0 | $0 | $32,152 |
| Neal David K | director | 2 | $25,750 | 0 | $0 | $25,750 |
| Gould Gregory A | CFO | 1 | $24,500 | 0 | $0 | $24,500 |
| Breidbart Scott | director | 1 | $18,012 | 0 | $0 | $18,012 |
| Williams Amanda M | director | 1 | $15,990 | 0 | $0 | $15,990 |
| Wesemann William | director | 2 | $10,186 | 0 | $0 | $10,186 |
Aclarion, Inc., a healthcare technology enterprise based in San Mateo, California, was founded in 2008 and operates within the United States. The company specializes in creating software for magnetic resonance spectroscopy (MRS) applications. Its primary product is the NOCISCAN-LS Post-Processor suite, which features two key components: NOCICALC-LS, designed to analyze MRS data from discs to quantify degenerative pain biomarkers, and NOCIGRAM-LS, a software tool that assists in clinical decision-making. The company adopted its current name, …
Over the last 12 months, insiders at Aclarion, Inc. have bought $176,647 and sold $0 worth of Aclarion, Inc. stock.
On average, over the past 5 years, insiders at Aclarion, Inc. have bought $81,755 and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Bond Ryan (director) — $50,059. Ness Brent (Chief Executive Officer) — $32,152. Neal David K (director) — $25,750.
The last purchase of 5,857 shares for transaction amount of $15,990 was made by Williams Amanda M (director) on 2026‑08‑17.
| 2026-08-17 | Williams Amanda M | director | 5,857 0.2344% | $2.73 | $15,990 | -14.08% | ||
| 2026-08-14 | Gould Gregory A | CFO | 10,000 0.4045% | $2.45 | $24,500 | -3.25% | ||
| 2026-08-13 | Ness Brent | Chief Executive Officer | 5,234 0.2046% | $2.31 | $12,091 | -0.83% | ||
| 2026-08-13 | Bond Ryan | director | 21,122 0.8471% | $2.37 | $50,059 | -0.83% | ||
| 2026-08-13 | Neal David K | director | 7,500 0.3046% | $2.40 | $18,000 | -0.83% | ||
| 2026-08-13 | Wesemann William | director | 2,150 0.0851% | $2.34 | $5,031 | -0.83% | ||
| 2026-05-12 | Breidbart Scott | director | 5,664 1.0722% | $3.18 | $18,012 | -19.05% | ||
| 2026-05-11 | Ness Brent | Chief Executive Officer | 6,289 1.2097% | $3.18 | $19,999 | -17.26% | ||
| 2026-05-11 | Neal David K | director | 2,500 0.4688% | $3.10 | $7,750 | -17.26% | ||
| 2026-05-06 | Wesemann William | director | 1,562 0.2947% | $3.30 | $5,155 | -21.34% | ||
| 2025-11-26 | Ness Brent | Chief Executive Officer | 10 0.0036% | $6.20 | $62 | -50.65% | ||
| 2023-02-16 | Thramann Jeffrey John | Executive Chairman | 1 – | $1,000.00 | $1,000 | -48.30% | ||
| 2022-12-29 | Lorbiecki John Paul | Chief Financial Officer | 22,404.44 0.2978% | $0.45 | $10,000 | +3.65% | ||
| 2022-12-29 | Ness Brent | Chief Executive Officer | 16,211 0.2623% | $0.54 | $8,807 | +3.65% | ||
| 2022-12-28 | Ness Brent | Chief Executive Officer | 2,289 0.0375% | $0.42 | $961 | +35.66% | ||
| 2022-04-21 | Wesemann William | 11,000 0.2249% | $4.35 | $47,850 | -68.80% |
| Increased Positions | 3 | +27.27% | 6,831 | +30.49% |
| Decreased Positions | 3 | -27.27% | 11,806 | -52.7% |
| New Positions | 2 | New | 6,472 | New |
| Sold Out Positions | 2 | Sold Out | 11,805 | Sold Out |
| Total Postitions | 11 | 0% | 17,427 | -22.21% |